Michael Koeris
Gründer bei Corvium, Inc.
Profil
Michael Koeris is the founder of Corvium, Inc. (founded in 2009) and Vulcan Biologics, Inc. (founded in 2019), where he holds the titles of Director and President, Secretary & Treasurer respectively.
Dr. Koeris is also the founder of GDMC Pte Ltd.
Currently, Dr. Koeris is a Director at Xeno Biosciences, Inc. In the past, he worked as a Principal at KPMG Consulting, Inc. and McKinsey GmbH & Co. KG.
Dr. Koeris obtained a doctorate degree from Boston University and completed undergraduate and graduate studies at Freie Universität Berlin.
Aktive Positionen von Michael Koeris
| Unternehmen | Position | Beginn |
|---|---|---|
Corvium, Inc.
 Corvium, Inc. Packaged SoftwareTechnology Services Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA. | Gründer | 01.03.2009 |
Xeno Biosciences, Inc.
 Xeno Biosciences, Inc. BiotechnologyHealth Technology Xeno Biosciences, Inc. operates as a biopharmaceutical company. It offers XEN-101, an oral formulation that shifts the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery. The company was founded by Hasan Celiker and is headquartered in Somerville, MA. | Direktor/Vorstandsmitglied | - |
Vulcan Biologics, Inc.
 Vulcan Biologics, Inc. BiotechnologyHealth Technology Vulcan Biologics, Inc. is a company that focuses on next-generation microbiome modulation. Vulcan Biologics is based in Irvine, CA and was founded by Michael Koeris, who has been the CEO since incorporation. The company aims to precisely and stably modulate any arbitrary microbiome, which is key to any commercial and clinical success. The company is building a broad platform to modulate any microbiome, focusing on integrative and next-generation approaches to achieve predictable stability in the engineered microbiomes. | Gründer | 29.10.2019 |
Ehemalige bekannte Positionen von Michael Koeris
| Unternehmen | Position | Ende |
|---|---|---|
McKinsey GmbH & Co. KG
 McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services McKinsey GmbH & Co. KG provides business consulting services. The company was founded on October 18, 2011 and is headquartered in Düsseldorf, Germany. | Corporate Officer/Principal | - |
| KPMG Consulting, Inc. | Corporate Officer/Principal | - |
Ausbildung von Michael Koeris
| Boston University | Doctorate Degree |
| Freie Universität Berlin | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
| KPMG Consulting, Inc. | Commercial Services |
Corvium, Inc.
Corvium, Inc. Packaged SoftwareTechnology Services Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA. | Technology Services |
Xeno Biosciences, Inc.
Xeno Biosciences, Inc. BiotechnologyHealth Technology Xeno Biosciences, Inc. operates as a biopharmaceutical company. It offers XEN-101, an oral formulation that shifts the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery. The company was founded by Hasan Celiker and is headquartered in Somerville, MA. | Health Technology |
Vulcan Biologics, Inc.
Vulcan Biologics, Inc. BiotechnologyHealth Technology Vulcan Biologics, Inc. is a company that focuses on next-generation microbiome modulation. Vulcan Biologics is based in Irvine, CA and was founded by Michael Koeris, who has been the CEO since incorporation. The company aims to precisely and stably modulate any arbitrary microbiome, which is key to any commercial and clinical success. The company is building a broad platform to modulate any microbiome, focusing on integrative and next-generation approaches to achieve predictable stability in the engineered microbiomes. | Health Technology |
McKinsey GmbH & Co. KG
McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services McKinsey GmbH & Co. KG provides business consulting services. The company was founded on October 18, 2011 and is headquartered in Düsseldorf, Germany. | Commercial Services |
